A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Reproducible Arterial Denudation Injury by Infrarenal Abdominal Aortic Clamping in a Murine Model

9.2K views

⸱

DOI:

10.3791/54755

⸱

November 24th, 2016

 ,  ,  , 

In This Article

Summary

Understanding the cellular and molecular mechanisms of re-endothelialization following arterial denudation injury is of paramount importance in preventing thrombosis and restenosis of arteries. Here we describe a protocol for reproducible arterial denudation injury of the infrarenal abdominal aorta. The procedure was developed to investigate the underlying mechanisms that regulate endothelial regeneration using mouse models.

Abstract

Percutaneous vascular interventions uniformly result in arterial denudation injuries that subsequently lead to thrombosis and restenosis. These complications can be attributed to impairments in re-endothelialization within the wound margins. Yet, the cellular and molecular mechanisms of re-endothelialization remain to be defined. While several animal models to study re-endothelialization after arterial denudation are available, few are performed in the mouse because of surgical limitations. This undermines the opportunity to exploit transgenic mouse lines and investigate the contribution of specific genes to the process of re-endothelialization. Here, we present a step-by-step protocol for creating a highly reproducible murine model of arterial denudation injury in the infrarenal abdominal aorta using external vascular clamping. Immunocytochemical staining of injured aortas for fibrinogen and β-catenin demonstrate the exposure of a pro-thrombotic surface and the border of intact endothelium, respectively. The method presented here has the advantages of speed, excellent overall survival rate, and relative technical ease, creating a uniquely practical tool for imposing arterial denudation injury in transgenic mouse models. Using this method, investigators may elucidate the mechanisms of re-endothelialization under normal or pathological conditions.

Introduction

Thrombosis and restenosis are serious early and late complications in patients who undergo percutaneous vascular interventions, such as endovascular balloon angioplasty and stenting1,2. Several strategies have been employed to address these complications, particularly dual antiplatelet therapy and drug-eluting stents. However, little focus has been placed on the underlying cause of thrombosis and restenosis, namely the loss of endothelial cell coverage (denudation). Denudation injury is an inevitable consequence of interventional procedures due to mechanical trauma to the blood vessel wall. This mechanical trauma can result in damage and removal of the protective endothelial layer and exposure of the basement membrane and vascular smooth muscle to circulating blood3. The loss of endothelial cells in these areas creates a pro-thrombotic and pro-inflammatory environment that not only promotes platelet adhesion and subsequent thrombosis, but also stimulates migration and proliferation of vascular smooth muscle cells resulting in neointimal thickening and restenosis4. These complications, and their associated therapies, lead to significant morbidity, most notably recurrent ischemic disease and bleeding events that impact human health.

Re-endothelialization of the denuded injury from the wound margins is of paramount importance in preventing thrombosis and restenosis5. Autopsy results and animal models have effectively demonstrated reduced rates of thrombosis with coverage of stent struts6,7. Drug-eluting stents, devised to decrease rates of restenosis by inhibiting smooth muscle proliferation and neointimal hyperplasia, result in significant impairments in arterial re-endothelialization and increasing rates of late thrombosis3. Unfortunately, understanding the mechanisms for re-endothelialization has been a slow process, largely limited by the lack of appropriate animal models8.

Several animal models for understanding the roles of endothelial cells and vascular smooth muscle cells following arterial injury have been created7,9,10. The rat carotid artery balloon injury model is the best characterized and has been employed to study the effects of denudation injury at the gross, cellular and molecular level11. Nevertheless, a highly reproducible murine model of arterial denudation injury with excellent survival rates is missing and much needed to take advantage of multiple transgenic lines available to better elucidate vascular regeneration in multiple settings.

This manuscript presents a murine model of arterial denudation injury that is reproducible and simple to perform. The approach has shown minimal morbidity and mortality in several transgenic lines. Because of the broad number of genetically modified mouse lines, this model may be used to elucidate the molecular mechanisms underlying re-endothelialization after denudation injury.

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: This protocol has been approved by the Animal Research Committee at the University of California Los Angeles.

1. Preoperative Preparation and Anesthesia

  1. Be sure to observe sterile technique throughout the procedure.
  2. Sterilize all surgical supplies using a steam autoclave.
  3. Turn on heated rodent surgical platform prior to anesthetic induction so that it may warm to appropriate temperature (37 °C) and place under stereomicroscope for visualization during surgical procedure.
  4. Place the mouse in the anesthesia induction chamber and induce with 4% isoflurane at a flow rate of 1 L/min.
    1. Carefully monitor the respiratory rate and footpad skin color of mouse during induction.
    2. After slowing of the respiratory rate, remove the mouse from the induction chamber and place on warmed pad for surgical preparation with face in separate nosecone and maintenance isoflurane concentration of 2.5%.
    3. Perform toe pinch to assess adequacy of anesthetic.
  5. Apply ophthalmic ointment to the corneas and administer preoperative carprofen (5 mg/kg) subcutaneously.
  6. Place mouse supine and use clippers to remove hair from abdomen.
  7. Prepare the surgical area with three alternating scrubs of povidone iodine and 70% isopropyl alcohol applied with sterile gauze pads.
  8. Place mouse supine on heated rodent surgical platform with face in nosecone and secure all extremities and carefully position mouse such that the abdomen is visible with the stereomicroscope.
  9. Place sterile, adhesive dressings along each edge of the prepared surgical area.
  10. Titrate isoflurane concentration to maintain adequate anesthesia during surgery while maintaining spontaneous respirations.

2. Infrarenal Aortic Clamping

  1. Make a 3 cm incision down the midline of the abdomen using a scalpel, starting approximately 0.5 cm inferior to the xiphoid process.
  2. Gently retract the skin with forceps and dissect skin away from the abdominal wall using fine scissors to cut the fine connective tissue.
  3. Apply 0.05-0.1 ml of 0.5% bupivacaine to the muscle wall and make a 2 cm incision into the abdominal wall to expose the abdominal organs.
    1. If bleeding occurs along abdominal wall, apply gentle pressure with a cotton-tipped applicator.
  4. Gently lift the intestines using saline-soaked cotton-tipped applicators.
    NOTE: Be careful to avoid blunt trauma to the jejunal and ileal arteries and place on a warm, sterile saline soaked gauze sponge outside the abdominal cavity.
    1. Cover the intestines with another warm, sterile saline soaked gauze sponge to avoid moisture loss.
  5. Place a retractor to lateralize the rectum and expose the retroperitoneum.
  6. Place small gauze pads as necessary for visualization of retroperitoneum keeping track of the number used.
  7. At the level of the inferior pole of the right kidney, use sharp dissecting forceps to make a retroperitonotomy lateral to the aorta.
    NOTE: Be careful not to injure the inferior vena cava or surrounding vessels.
    1. Bluntly dissect retroperitoneal tissue off the aorta being careful not to perforate the inferior vena cava or surrounding vasculature.
  8. Place the vascular clamp over the aorta for at least 1 min, or other specified time, and verify occlusion by visually observing lack of pulsatility in distal aorta.
  9. Remove the vascular clamp and verify hemostasis. Hemostasis is achieved and ensured when no active extravasation of blood is seen.
    1. Confirm extravasation by adding 0.5 ml saline into abdominal cavity and assessing if the saline becomes increasingly blood-tinged. If this is the case, apply gentle pressure using the saline-soaked applicator for 1 min to ensure hemostasis.
  10. Remove any gauze pads placed to aid in visualization of retroperitoneum and replace intestines in situ into abdomen.
  11. Irrigate the abdominal cavity using pre-warmed sterile saline.

3. Closure of Laparotomy and Skin

  1. Close the abdominal wall muscle layer using a 5-0 braided, absorbable single running suture.
  2. Close skin with 1-3 drops of polymer adhesive and then subsequently with wound clips once the adhesive is set.

4. Recovery and Postoperative Assessment

  1. Transfer the mouse to a recovery cage on a heating pad with food and water on the floor of the cage.
  2. Closely monitor the mouse for signs of respiratory distress. Administer carprofen (5 mg/kg) daily for 48 hr postoperatively per institution guidelines.
    1. Do not leave an animal unattended until it has regained sufficient consciousness to maintain sternal recumbency.
  3. Return the mouse to a normal cage with food and water.
    1. Do not return an animal that has undergone surgery to the company of other animals until fully recovered.
  4. Assess wound on a daily basis for dehiscence and remove clips on postoperative day 14.

5. Aortic Dissection and Staining

  1. Select mice for sacrifice based on the specific time point of interest following denudation injury.
  2. Sacrifice mice via isoflurane inhalation and immediately inject with 5 mg methacholine chloride to cause vascular smooth muscle relaxation.
  3. Upon confirmation of death by respiratory cessation, lack of corneal reflex and lack of movement, perfuse with 4% paraformaldehyde in phosphate buffered saline at a perfusion pressure of 100 mmHg via the left heart ventricle for 10 min.
  4. Use a dissecting stereomicroscope to carefully separate the intact abdominal aorta from the surrounding tissues.
  5. Transect the aorta rostral to the renal arteries and caudal to the iliac bifurcation and opened via a longitudinal incision along the dorsal surface.
  6. Pin the aorta flat on a 35 mm silicone coated dish with the luminal side up for fixation for no less than 2 hr but no more than 12 hr. Subsequently, the tissue can be either embedded for sectioning or used in en face whole-mount immunocytochemistry.
  7. Mount stained aortas with luminal side facing the coverslip on glass slides for confocal microscopy.

Access restricted. Please log in or start a trial to view this content.

Results

Eighty-five mice have undergone the survival surgical technique described in this report for infrarenal abdominal aortic clamping. The overall survival rate was 85.9%. Operative complications included intestinal bleeding and great vessel perforation, resulting in 5.9% and 3.5% mortality respectively (Table 1). After recovery from anesthesia, mice walk normally and show no signs of ischemic injury to the inferior limbs. No weight loss or lack of appetite were noted.

Access restricted. Please log in or start a trial to view this content.

Discussion

Arterial denudation injury due to percutaneous interventions, such as balloon angioplasty and vascular stenting, result in early and late vascular thrombosis and restenosis and contributes to recurrent ischemic events3,12. Interestingly, surgical vascular clamping has also been implicated as a cause of arterial denudation, expanding the scope of the problem to patients undergoing any vascular procedure, whether percutaneous or open13. While impaired re-endothelialization is a fairly recognized cause...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by grants from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Training Program to ASS and AIM, Philip J. Whitcome Fellowship to AIM, and National Institutes of Health (HL130290) to MLIA.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Zeiss Discovery.V12 StereomicroscopeZeiss495037-9904-000
Rodent Heated Surgical PlatformProtech InternationalRES4000Heated platform for body temperature maintenance with nosecone for anesthestic maintenance and on which surgical procedure is performed
IsofluraneHenry Schein500334% Induction; 2.5% Maintenance
Isoflurane VaporizerSummit Medical Equipment470062
Stryker T/Pump Warm Water RecirculatorKent ScientificTP-700
Artifical Tears Lubricant Opthalmic OintmentAkorn Animal Health17478-162-35
Carprieve (Carprofen)Norbrook LaboratoriesNDC 55529-131-01
Oster™ A5 Professional Animal ClipperM.Schneider & Sons Inc.78005010Use with animal clipper size 40
Adjustable Wire RetractorFine Science Tools17004-05
Schwartz Micro Serrefines - Sharp BendFine Science Tools18052-03
Surgical InstrumentsFine Science Toolssharp dissecting forceps, blunt forceps, fine scissors, spring scissors, hemostat
0.5% MarcaineHospira0409-1610-50
5-0 Suture, VicrylFisher ScientificNC0189890tapered needle
VetbondFisher ScientificNC0304169
Falcon® 35 mm Not TC-Treated Easy-Grip Style Bacteriological Petri DishCorning351008
Sylgard 184 Silicone Elastomer KitDow Corning3097358-1004
Dissecting pinsFisher ScientificNC9681411

References

  1. Farooq, V., Gogas, B. D., Serruys, P. W. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv. 4, 195-205 (2011).
  2. Tada, T., et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC Cardiovasc Interv. 6, 1267-1274 (2013).
  3. Otsuka, F., et al. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol. 9, 439-453 (2012).
  4. Kipshidze, N., et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 44, 733-739 (2004).
  5. Finn, A. V., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 115, 2435-2441 (2007).
  6. Joner, M., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 48, 193-202 (2006).
  7. Joner, M., et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 52, 333-342 (2008).
  8. McDonald, A. I., Iruela-Arispe, M. L. Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury. Vascul Pharmacol. 72, 9-15 (2015).
  9. Fingerle, J., Tina Au, Y. P., Clowes, A. W., Reidy, M. A. Intimal Lesion Formation in Rat Carotid Arteries after Endothelial Denudation in Absence of Medial Injury. Arteriosclerosis. 10, 1082-1087 (1990).
  10. Granada, J. F., et al. Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine. Circ Cardiovasc Interv. 4, 447-455 (2011).
  11. Tulis, D. A. Rat carotid artery balloon injury model. Methods Mol Med. 139, 1-30 (2007).
  12. Bavry, A. A., Bhatt, D. L. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet (London, England). 371, 2134-2143 (2008).
  13. Gucu, A., et al. Effects of temporary vascular occluder poloxamer 407 Gel on the endothelium. J Cardiothorac Surg. 8, (2013).
  14. Holt, A. W., Tulis, D. A. Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies. ISRN Minim Invasive Surg. 2013, (2013).
  15. Nam, D., et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol. 297, 1535-1543 (2009).
  16. Lindner, V., Fingler, J., Reidy, M. A. Mouse Model of Arterial Injury. Circ Res. 73, 792-796 (1993).
  17. Kumar, A., Lindner, V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 17, 2238-2244 (1997).
  18. Hehrlein, C., Weinschenk, I., Metz, J. Long period of balloon inflation and the implantation of stents potentiate smooth muscle cell death. Possible role of chronic vascular injury in restenosis. Int J Cardiovasc Intervent. 2, 21-26 (1999).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Re-endothelializationVascular InjuryImmunocytochemistryFibrinogen StainingEndothelial RegenerationTransgenic MiceSurgical Procedure